Should Higher Doses of Anti-Hepatitis B Virus (HBV) Therapy Be Considered Post-Liver Transplant (LTx) in HBV DNA Positive Recipients: A Case Report?

被引：0
|
作者：
Patel, Vishal [1 ]
Mukerji, Amar [1 ]
Karachristos, Andreas [1 ]
Maloo, Manoj [1 ]
Jain, Ashokkumar [1 ]
机构：
[1] TUHS, Philadelphia, PA USA
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [31] RECURRENCE OF HEPATITIS-B VIRAL (HBV) DISEASE IN LIVER-TRANSPLANT RECIPIENTS - IMPACT OF PRETRANSPLANT HBV DNA SCREENING BY LIQUID-PHASE HYBRIDIZATION ASSAY
    MIN, A
    BORCICH, A
    LEUNG, L
    HYTIROGLOU, P
    EMRE, S
    MILLER, C
    THUNG, S
    BODENHEIMER, HC
    HEPATOLOGY, 1993, 18 (04) : A338 - A338
  • [32] Comparison of three different hepatitis B virus (HBV) DNA assays in monitoring of anti-viral therapy
    Chan, HL
    Leung, NW
    Lau, TC
    Wong, ML
    Sung, JJ
    HEPATOLOGY, 1999, 30 (04) : 636A - 636A
  • [33] Long-term efficacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts
    Yoshizawa, Atsushi
    Yamashiki, Noriyo
    Ueda, Yoshihide
    Kaido, Toshimi
    Okajima, Hideaki
    Marusawa, Hiroyuki
    Chiba, Tsutomu
    Uemoto, Shinji
    HEPATOLOGY RESEARCH, 2016, 46 (06) : 541 - 551
  • [34] Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy
    Rui, Shaozhen
    Yan, Jun
    Zhang, Hui
    Wang, Zhengfeng
    Zhou, Wence
    MEDICINE, 2017, 96 (30)
  • [35] Efficacy of extended lamivudine therapy against hepatitis B virus (HBV) infection in hematopoietic stem cell transplant (HSCT) recipients
    Hsiao, LT
    Chiou, T
    Liu, J
    Yen, C
    Wang, W
    Lin, Y
    Chu, C
    Chao, T
    Yang, M
    Chen, P
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 114 - 114
  • [36] Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B
    Yuen, MF
    Ng, IOL
    Fan, ST
    Yuan, HJ
    Wong, DKH
    Yuen, JCH
    Sum, SSM
    Chan, AOO
    Lai, CL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : 2032 - 2037
  • [37] THE IMPROVED PROPHYLACTIC STRATEGY OF HEPATITIS B VIRUS RECURRENCE AFTER LIVER TRANSPLANTATION FOR THE CANDIDATES WITH SERUM POSITIVE HBV DNA
    Lu, An-wei
    Zheng, Shu-sen
    Wu, Mei-ping
    Yang, Rong-wei
    Wang, Bao-hang
    LIVER TRANSPLANTATION, 2008, 14 (07) : S181 - S181
  • [38] Impact of the timing of hepatitis B virus (HBV) identification and anti-HBV therapy initiation on the risk of adverse liver outcomes in patients receiving cancer therapy.
    Hwang, Jessica
    Suarez-Almazor, Maria E.
    Cantor, Scott B.
    Barbo, Andrea G.
    Lin, Heather Y.
    Ahmed, Sairah
    Gregor, Mariana Chavez-Mac
    Donato-Santana, Christian
    Eng, Cathy
    Ferrajoli, Alessandra
    Fisch, Michael
    McLaughlin, Peter
    Simon, George R.
    Rondon, Gabriela
    Shpall, Elizabeth J.
    Lok, Anna S. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Prediction of anti-hepatitis B E-positive reactivation by quantitative detection of wild-type and precore mutant HBV-DNA.
    Oketani, M
    Oketani, K
    Wu, GY
    Arima, T
    HEPATOLOGY, 1998, 28 (04) : 480A - 480A
  • [40] Incidence of Post-Liver Transplant Hepatic Dysfunction After Sustained Virologic Response Following Direct-Acting Anti-Hepatitis C Therapy
    Jain, Ashokkumar
    Riley, Thomas R., III
    Krok, Karen L.
    Schreibman, Ian
    Karamchandani, Dipti M.
    Liao, Xiaojie
    Tian, Ye
    Dohi, Takehiko
    Kadry, Zakiyah
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (03) : 345 - 352
12345